Call Us Today @ 0172 - 4680800 | info@indswift.com | NSE - BSE

FACILITIES

A unique and unmatched excellence in pharmaceuticals manufacturing with highest reliance of product quality attributes is our corporate strength . Ind-Swift's multipurpose, multilocation manufacturing set-ups are acrossspread across the lush-green plains of northern Indian states viz Himachal Pradesh, Haryana and Jammu and Kashmir. The locations are environmental pollution free and together offer approx.12 lacs sq. ft of newly constructed plants with state of the art facilities for pharma manufacturing.

The facilities are built according to current guidelines of USFDA, MHRA, EU, and WHO, and accreditations with ISO 14000 series standard.

A strong and ever vigilant Quality Assurance System forms the backbone of our continuing compliance to stringent regulatory guidelines, backed by latest equipments and instrumentation system. We achieve constant compliance to product quality.attributes with an enviable cost of efficiency. It is always our strong endeavor to continuously invest in newer products, process technologies and look out for new horizons in pharmaceutical business to establish our well earned leadership.

 

EQUIPMENTS

All of the above facilities house the latest, automated equipments, operating with pre-programmed logic controllers and a highly qualified and trained staff to produce products conforming to defined quality attribute .
Some of the examples of these equipments are :

  • Fully automatic and integrated lines for filling of Ampoules and vials.
  • Dehydrogenating and Sterilizing tunnel.
  • Bottles (Glass/ PET) washing, filling and sealing machines.
  • Heavy duty granulation, blenders
  • High speed tablet compression machine
  • Tablet Auto coaters
  • Capsule Filling Inspection and Polishing machines
  • Blister packaging machine (PVC and ALU-ALU)
  • Product processing under Isolators (for Oncologicals)
 All the operations are complementary by a highly efficient classified Air Handling System with pressure gradients and an continuously operating water generating, storage and distribution system to supply high
 purity water.
 
 The Manufacturing facilities are strategically grouped so as to offer dedicated environment for the manufacturing of :
  • General category formulations
  • Beta lactum
  • Steroids and hormones
  • Cephalosporins
  • Oncologicals
  • Soft Gelatin capsules
  • Herbal and Neutraceuticals
 These facilities together produce a diverse range of dosage forms like :
  • Oral solutions and suspensions
  • Dry syrups (General, beta lactum and Cephalosporins)
  • Tablets with all different technologies
  • Hard Gelatin Capsules
  • Soft Gelatin Capsules
  • Liquid and Dry powder injectables
  • Dermatological
  • Eye/ Ear drops
 

CAPACITY

 Ind-Swift Ltd is proud to have an enviable manufacturing capacity to process above range of products.
The current annualized capacity is :
  • 2300 million Tablets
  • 64 million Ampoules
  • 27 million Vialss
  • 84 million Capsules
  • 18 million Dermatological products
  • 62 million Oral liquid bottles